mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |